What a Belgian conglomerate really earns — and what its salmon bet tells you about how it thinks

Ackermans & Van Haaren's shares jumped nearly 8% after the company released first-half 2026 results, posting a net profit of €339.6 million — up 24% from the same period last year. The headline is easy to understand. What the numbers actually say about how this 150-year-old holding company generates and allocates capital is worth a closer look, because the story isn't just that it grew profits. It's that nearly every engine fired at once, the Growth Capital arm stopped dragging, and the balance sheet was thick enough to fund a €93 million entry into salmon farming on the same day.

For American investors, Ackermans & Van Haaren is unlikely to appear on a screen sorted by market cap or sector. It trades on the Euronext Brussels, carries the BEL20 index, and runs a business that resembles a diversified industrial holding rather than any single-name company. The key to understanding the stock is understanding the structure: AvH makes money by owning controlling stakes in companies that produce cash flow across uncorrelated industries, then distributes a chunk of that cash flow back to shareholders. The H1 2026 results show a machine that is running — and getting better at it.

How the earnings broke down

The €339.6 million net profit for the first half came from two sources. Core segments — the long-held participations in marine engineering and dredging (DEME), private banking (Delen and Van Breda), industrial coatings (CFE), and palm oil (SIPEF) — contributed €322.8 million, up 13% from the prior year. That is not a one-company story. Four unrelated businesses, in four unrelated industries, all posted higher results at the same time. The diversification is doing the work.

Growth Capital, which had weighed on AvH's overall profit in earlier years, turned the corner. The segment moved from a drag to a contributor. You don't need the exact line-item figure to understand what matters: the part of the portfolio that used to be the weak link is no longer holding the average back.

On the income statement, operating profit held steady at €327.9 million and total turnover came in at €3,030.2 million. Earnings per share rose to €10.39 from €8.36 a year earlier. The group also raised its full-year outlook to net profit growth of more than 10%, up from earlier guidance that had simply pointed to roughly flat performance versus the record 2025 year of €593 million. A guidance upgrade after H1, not before, carries more weight than a projection made in winter.

Cash and safety

The balance sheet tells a complementary story. Net cash reached €524.4 million at the end of June, up from €431 million at the same point last year. Shareholders' equity grew to €5,898.5 million. DEME, the marine engineering flagship, sits at a net debt-to-EBITDA ratio of just 0.3 — meaning it carries almost no leverage relative to its earnings power. In a holding company, the safety of the largest subsidiary matters because its trouble becomes the holding company's trouble. DEME is not in trouble.

These numbers matter for the salmon bet.

The salmon question

On the same day as the results, AvH announced a €93 million investment for a 37.5% stake in Grieg Aqua, the holding company that owns just over 50% of Oslo-listed Grieg Seafood, one of Europe's leading salmon producers. The move comes as the Grieg family transitions ownership into its fourth and fifth generations, with AvH stepping in as a professional, long-term institutional partner.

The obvious question: why salmon? The less obvious answer is the one that matters for evaluating the holding company. The €93 million is about 17% of the group's net cash and roughly 1.6% of its €5.9 billion equity base. It is a meaningful bet — not a small experiment — but it is also a fraction that the balance sheet can absorb if things don't go perfectly. That is what a holding company with €524 million in net cash and diversified income streams can do that a single-industry company cannot. One sector underperforms; the rest keeps funding the strategy.

Salmon aquaculture is cyclical — salmon prices move with disease, feed costs, and supply gluts. It's also a long-term growth market, with protein demand rising and wild catch flat. AvH is not going all in; it's entering through a minority stake in a holding company, not buying Grieg Seafood directly. That is a conservative entry into a volatile industry. The structure itself is a clue about the company's risk tolerance.

Valuation and the dividend

At a share price of approximately €280 following the 8% jump, AvH trades at a trailing P/E around 14x and a forward P/E in the low-to-mid 12x range. For a diversified holding with 24% profit growth and an upgraded full-year outlook, that multiple is reasonable — not cheap, not expensive. The forward P/E of about 12.4x implies the market expects the upgraded guidance to materialize, which is a fair price to pay when the companies inside the holding are actually delivering.

The dividend comes in at €4.60 per share, up from €3.81 last year — a 21% increase. At current prices, the yield sits around 1.7%. The payout ratio, at roughly 21% of earnings, is very conservative. A holding company that keeps three-quarters of its earnings and deploys the rest into new investments and equity growth is prioritizing compounding over income. That's fine if you're okay with the dividend growing slowly rather than delivering a high yield today. It's not a stock for yield-chasers.

How to think about this holding company

The investor takeaway is structural, not speculative. AvH is a diversified Belgian holding company whose profit growth came from multiple, uncorrelated sources in the first half of 2026. The Growth Capital arm stopped being a headwind. The balance sheet has enough cash to fund new bets without overleveraging. The dividend is growing but the yield is modest. The salmon investment is a test of the company's discipline in sectors it hasn't operated in before.

The risk is not any single business inside the portfolio. It's execution on new investments and the possibility that a growth-capital bet like salmon drags again. The salmon industry is volatile, and AvH's track record there starts at zero.

The reward is the compounder model: a holding company that generates cash across multiple industries, keeps its payout ratio well below 25%, and reinvests the rest. If the upgraded guidance holds and the €339.6 million H1 pace continues into a second half that delivers the promised 10%+ full-year growth, the earnings per share trajectory justifies the multiple. The stock is priced for good, not great. That means it doesn't need a perfect H2 to justify the entry — it just needs to deliver what management now expects.

The 8% pop after the results was the market rewarding a clean quarter. Whether that rally becomes a trend depends on whether the second half confirms the upgraded outlook and whether the salmon entry proves to be a well-structured minority stake or an expensive lesson. Both outcomes fit inside the factor stack. The difference is time.